Abstract
A cohort of 197 Medicaid-insured patients presenting for treatment in Kaiser Permanente's out-patient chemical dependency treatment program were observed the year prior to their program intake visit and followed for 3 years afterwards, to compare their medical costs and utilization to demographically matched commercially insured patients entering the same programs. The Medicaid-insured patients on average incurred medical costs 60% higher than non-Medicaid patients during the 12-month preintake period ($5402 vs $3277). During the 3 years subsequently, however, both groups of chemical dependency patients displayed significant declines in medical costs, averaging 30% from the baseline period to the third year of follow-up. Cost trends reflected declines in use of hospital days, emergency department visits, and nonemergent outpatient visits. These results may help address concerns among Medicaid managed care providers and payers by giving a more realistic account of the long-term costs of this group of high-utilizing enrollees.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alexandre PK, Roebuck MC, French MT, Chitwood DD, McCoy CB. Problem drinking, health services utilization, and the cost of medical care. In:Services Research in the Era of Managed Care. New York: Kluwer Academic/Plenum; 2001:285–298. Galanter M, ed.Recent Developments in Alcoholism; Vol 15.
French MT, McGeary KA, Chitwood DD, et al. Chronic illicit drug use, health services utilization and the cost of medical care.Social Science Medicine. 2000;50:1703–1713.
Holder HD, Lennox RD, Blose JO. The economic benefits of alcoholism treatment: a summary of twenty years of research.Journal of Employee Assistance Research. 1992;1:63–82.
McGeary KA, French MT. Illicit drug use and emergency room utilization.Health Services Research. 2000;35:153–169.
Parthasarathy S, Weisner C, Hu TW, et al. Association of outpatient alcohol and drug treatment with health care utilization and cost: revisiting the offset hypothesis.Journal of Studies on Alcohol. 2001;62:89–97.
Parthasarathy S, Mertens J, Moore C, et al. Utilization and cost impact of integrating substance abuse treatment and primary care.Medical Care. 2003;41:357–367.
Stein MD, O'Sullivan PS, Ellis P, et al. Utilization of medical services by drug abusers in detoxification.Journal of Substance Abuse. 1993;5:187–193.
Jones KR, Vischi TR. Impact of alcohol, drug abuse and mental health treatment on medical care utilization. A review of the research literature.Medical Care. 1979;17:1–82.
Holder HD. The cost offsets of alcoholism treatment. In:The Consequences of Alcoholism. New York: Plenum Press; 1998;361–374. Galanter M, ed.Recent Developments in Alcoholism; Vol 14.
Burke KC, Meek WJ, Krych R, et al. Medical services use by patients before and after detoxification from benzodiazepine dependence.Psychiatric Services. 1995;46:157–160.
Hoffmann NG, DeHart SS, Fulkerson JA. Medical care utilization as a function of recovery status following chemical addictions treatment.Journal of Addictive Diseases. 1993;22:97–108.
Lennox RD. Cost-offsets of drug-abuse treatment provided in the private sector. Invited paper presented at: Annual Meeting of the Association for Health Services Research; June 27–29, 1993; Washington, DC.
Walter LJ, Parthasarathy S, Allen S, et al. Medicaid patients in a private health maintenance organization: patterns of chemical dependency treatment.The Journal of Behavioral Health Services Research. 2002;29:1–14.
SAS Institute Inc.SAS/STAT(c) User's Guide, Version 8, Vols 1 and 2. Cary, NC: SAS Institute Inc; 1999:3884.
Selby JV. Linking automated databases for research in managed care settings.Annals of Internal Medicine. 1998;127:719–724.
Ray GT, Lieu TA, Weinstein MC, et al. Comparing the medical expenses of children with Medicaid and commercial insurance in an HMO.The American Journal of Managed Care. 2000;6:753–760.
D'Agostino Jr RB. Tutorial in biostatistics: propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.Statistics in Medicine. 1998;17:2265–2281.
Diehr P, Yanez D, Ash A, et al. Methods for analyzing health care utilization and costs.Annual Review Public Health. 1999;20:125–144.
McCullagh P, Nelder JA.Generalized Linear Models. New York: Chapman & Hall; 1989.
Wolfinger R, O'Connell M. Generalized linear mixed models: a pseudo-likelihood approach.Journal of Statistical Computation and Simulation. 1993;48:233–243.
Health Care Financing Administration.A Profile of Medicaid Chart Book 2000. Rockville, Md: Health Care Financing Administration; 2000.
Salganicoff A. Medicaid and managed care: implications for low-income women.Journal of the American Medical Women's Association. 1997;52:78–80.
American Society of Addiction Medicine.ASAM Patient Placement Criteria. 2nd ed. Chevy Chase, Md: American Society of Addiction Medicine; 2000.
Stein MD. Medical consequences of substance abuse.Psychiatric Clinics of North America. 1999;22:351–370.
Felt-Lisk S, Dodge R, McHugh M.Trends in Health Plans Serving Medicaid—2000 Data Update. Washington, DC: The Kaiser Commission on Medicaid & the Uninsured; 2001.
Ettner SL, Frank RG, Mcguire TG. Risk adjustment alternatives in paying for behavioral health care under Medicaid.HSR: Health Services Research. 2001;36:793–811.
Ettner SJ, Johnson S. Do adjusted clinical groups eliminate incentives for HMOs to avoid substance abusers: evidence from the Maryland Medicaid HealthChoice Program.Journal of Behavioral Health Services Research. 2003;30:63–77.
Partnership HealthPlan of California.Partnership HealthPlan of California 2000–2001 Annual Report. Suisun City, Calif: Partnership HealthPlan of California; 2001.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Walter, L.J., Ackerson, L. & Allen, S. Medicaid chemical dependency patients in a commercial health plan. The Journal of Behavioral Health Services & Research 32, 253–263 (2005). https://doi.org/10.1007/BF02291826
Issue Date:
DOI: https://doi.org/10.1007/BF02291826